 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase
|
 |
|
Title:
|
 |
3-d structure of a hp-rnase
|
|
Structure:
|
 |
Ribonuclease 1. Chain: a, b. Synonym: rnase 1, hp-rnase. Engineered: yes. Mutation: yes. Other_details: 100a formilmethionine (fme)
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Organ: pancreas. Plasmid: pm7. Gene: pm7. Expressed in: escherichia coli. Expression_system_taxid: 469008. Other_details: synthetic gene
|
|
Resolution:
|
 |
|
1.65Å
|
R-factor:
|
0.177
|
R-free:
|
0.236
|
|
|
Authors:
|
 |
J.Pous,A.Canals,S.S.Terzyan,A.Guasch,A.Benito,M.Ribo, M.Vilanova,M.Coll
|
Key ref:
|
 |
J.Pous
et al.
(2000).
Three-dimensional structure of a human pancreatic ribonuclease variant, a step forward in the design of cytotoxic ribonucleases.
J Mol Biol,
303,
49-60.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
21-Feb-00
|
Release date:
|
16-Feb-01
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P07998
(RNAS1_HUMAN) -
Ribonuclease pancreatic
|
|
|
|
Seq: Struc:
|
 |
 |
 |
156 a.a.
121 a.a.*
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 7 residue positions (black
crosses)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.1.27.5
- Pancreatic ribonuclease.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Endonucleolytic cleavage to nucleoside 3'-phosphates and 3'-phosphooligonucleotides ending in C-P or U-P with 2',3'-cyclic phosphate intermediates.
|
 |
 |
 |
 |
 |
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
1 term
|
 |
|
Biochemical function
|
nucleic acid binding
|
5 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
303:49-60
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Three-dimensional structure of a human pancreatic ribonuclease variant, a step forward in the design of cytotoxic ribonucleases.
|
|
J.Pous,
A.Canals,
S.S.Terzyan,
A.Guasch,
A.Benito,
M.Ribó,
M.Vilanova,
M.Coll.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
We have determined the crystal structure of a human pancreatic ribonuclease or
RNase 1 variant at 1.65 A resolution. Five residues in the N-terminal region
were substituted by the corresponding amino acids of the bovine seminal RNase.
In addition, a Pro to Ser mutation was present at position 50. The substitution
of part of the N terminus has been critical both in improving the expression of
this enzyme as a recombinant protein and in achieving its crystallisation. The
determination of the crystal structure revealed the characteristic RNase fold
including a V-shaped beta-sheet and three alpha-helices. It differs from its
bovine RNase orthologue mainly in the loop regions. The active-site cleft shows
a similar architecture to that of its bovine counterpart, with the essential
residues occupying equivalent positions. In the present structure, however,
His119 is displaced as it is in the structure of RNase A at high pH. An
interaction model of human ribonuclease with the ribonuclease inhibitor,
together with inhibition assays, indicate that, in contrast to RNase A, the
modification of the loop beta4beta5 is not enough to avoid inhibition. This
study represents the first crystallographic approach to the human enzyme, and
should constitute an invaluable tool for the design of ribonuclease variants
with acquired cytotoxic properties.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 4.
Figure 4. Protein-protein interactions. (a) and (b) Electrostatic surface of PM7 showing the acidic patch (a) that
interacts with the basic active-site cleft (b) of molecules A and B in the asymmetric unit. (c) Molecules A and B as
they pack in the crystal, with one molecule occupying the active site cleft of the other. (d) Electrostatic surface show-
ing interaction between neighbouring molecules A and B from different asymmetric units which closely resembles the
swapped dimer of RNase A. The Figures were generated with GRASP (Nicholls et al., 1991).
|
 |
Figure 5.
Figure 5. Superimposed structures of molecules A
(blue) and B (yellow) of PM7, and RNase A (red; PDB
code 7RSA) at the loop b4-b5. Common residues are
labelled in black, whereas differences in the primary
structure are highlighted by the use of labels coloured
according to the molecule.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2000,
303,
49-60)
copyright 2000.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Merlino,
G.Avella,
S.Di Gaetano,
A.Arciello,
R.Piccoli,
L.Mazzarella,
and
F.Sica
(2009).
Structural features for the mechanism of antitumor action of a dimeric human pancreatic ribonuclease variant.
|
| |
Protein Sci, 18,
50-57.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
Y.Sato,
and
M.Nishida
(2009).
Electric charge divergence in proteins: insights into the evolution of their three-dimensional properties.
|
| |
Gene, 441,
3.
|
 |
|
|
|
|
 |
H.Yamada,
T.Tamada,
M.Kosaka,
K.Miyata,
S.Fujiki,
M.Tano,
M.Moriya,
M.Yamanishi,
E.Honjo,
H.Tada,
T.Ino,
H.Yamaguchi,
J.Futami,
M.Seno,
T.Nomoto,
T.Hirata,
M.Yoshimura,
and
R.Kuroki
(2007).
'Crystal lattice engineering,' an approach to engineer protein crystal contacts by creating intermolecular symmetry: crystallization and structure determination of a mutant human RNase 1 with a hydrophobic interface of leucines.
|
| |
Protein Sci, 16,
1389-1397.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.J.Johnson,
J.G.McCoy,
C.A.Bingman,
G.N.Phillips,
and
R.T.Raines
(2007).
Inhibition of human pancreatic ribonuclease by the human ribonuclease inhibitor protein.
|
| |
J Mol Biol, 368,
434-449.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Rodríguez,
A.Benito,
M.Ribó,
and
M.Vilanova
(2006).
Characterization of the dimerization process of a domain-swapped dimeric variant of human pancreatic ribonuclease.
|
| |
FEBS J, 273,
1166-1176.
|
 |
|
|
|
|
 |
D.Gaur,
and
J.K.Batra
(2005).
Role of aspartic acid 121 in human pancreatic ribonuclease catalysis.
|
| |
Mol Cell Biochem, 275,
95.
|
 |
|
|
|
|
 |
F.Sica,
A.Di Fiore,
A.Zagari,
and
L.Mazzarella
(2003).
The unswapped chain of bovine seminal ribonuclease: Crystal structure of the free and liganded monomeric derivative.
|
| |
Proteins, 52,
263-271.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.A.Leland,
K.E.Staniszewski,
B.M.Kim,
and
R.T.Raines
(2001).
Endowing human pancreatic ribonuclease with toxicity for cancer cells.
|
| |
J Biol Chem, 276,
43095-43102.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|